As the pathophysiology of the association between NAFLD development and incident diabetes has been well illustrated, which involves insulin resistance, increased lipogenesis, overproduced hepatic glucose, and dysregulated hepatokines thus contributing to β-cell dysfunction, the change in NAFLD status might modify the risk of diabetes (15, 16). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.